Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
This push has created pricing pressure on long-listed branded drugs whose Re-examination Periods have expired
CagriSema is a fixed-dose combination of two medications in a single once-weekly injection: cagrilintide (2.4 mg), a long-acting amylin analog, and semaglutide (2.4 mg), the same GLP-1 receptor agonist found in Wegovy and Ozempic
Responsible microdosing requires structured monitoring, including three core commitments: regular laboratory tests, a symptom log, and clinician-supervised dose adjustments, with practical checkpoints such as a symptom review at week 2 and weekly entries for weight and hydration
It is a selective amylin receptor agonist, meaning it works through a different appetite-regulating hormone pathway
Neutralizes free radicals and oxidative stress
US$ 27.94
US$ 22.22
US$ 25.26
US$ 23.16
